Purchase Order 15B10724P00000018

Award Date 10/1/23
Potential Completion Date 10/31/23
Potential Value $161
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Mckesson Corporation will provide pharmaceutical products to the Federal Bureau of Prisons under a firm fixed-price purchase order valued at approximately $406,000. The contract was awarded by the Bureau of Prisons' Federal Correctional Institution in Cumberland, Maryland to fulfill its pharmaceutical needs through December 2023. McKesson will deliver the products from its distribution center in Irving, Texas. No subcontractors or set-aside designations were specified. This order is likely...
The Department of Justice Bureau of Prisons Federal Correctional Institution Cumberland awarded Mckesson Corporation, doing business as Mckesson, a $619,240 purchase order contract to deliver open market pharmaceuticals from August through September 2023. As one of the largest providers of healthcare products and services to correctional facilities, Mckesson will supply a range of prescription and over-the-counter medications to the Bureau of Prisons institution located in Irving, Texas. The...
Mckesson Corporation will provide pharmaceutical supplies to the Federal Bureau of Prisons under a $450,000 firm fixed-price purchase order awarded by the Department of Justice. As one of the largest pharmaceutical distributors in the U.S., Mckesson will deliver drugs and medical supplies to the Federal Correctional Institution in Cumberland, Maryland in support of the Bureau of Prisons' healthcare programs at that facility. The single-award order runs from December 1, 2023 through December...
The Department of Justice Bureau of Prisons Federal Correctional Institution Cumberland awarded Mckesson Corporation a $157,940.04 firm fixed price delivery order contract to supply inmate drugs for the month of October 2023. Performance will take place in Irving, Texas under contract number 15-1060, running from October 1st through 31st, 2023. As one of the largest providers of healthcare products and services to correctional facilities, Mckesson will deliver pharmaceuticals to the Bureau of...
Mckesson Corporation, doing business as Mckesson, has been awarded a $583,440 firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock to provide pharmaceuticals. The contract has a one-month period of performance from November 1-30, 2023. Mckesson will deliver the pharmaceutical products to its place of performance in Irving, Texas. No major subcontractors or set aside designations were indicated. The Department of Justice Bureau of...
Mckesson Corporation will provide pharmaceuticals to the Department of Justice Bureau of Prisons under a $10,116.50 firm fixed price purchase order issued on September 19, 2023. Performance will take place in Irving, Texas, concluding on September 30, 2023. As the prime contractor, Mckesson will supply drugs to the Federal Correctional Complex Pollock, supporting the Bureau of Prisons' healthcare operations at this facility. No subcontractors or set aside designations were indicated. Mckesson...
Mckesson Corporation will provide medical and pharmaceutical supplies to the Federal Bureau of Prisons under a firm fixed-price purchase order valued at ten thousand forty-seven dollars and seventeen cents ($10,047.17). The contract was awarded by the Department of Justice Bureau of Prisons Federal Correctional Complex Coleman facility located in Irving, Texas, to fulfill its August 2023 requirements. McKesson will deliver the requested products and services between August 1st and September 5th,...
Mckesson Corporation will provide pharmaceuticals to the Department of Justice Bureau of Prisons under a $2,392 firm fixed price purchase order issued on July 11, 2023. Performance will take place in Irving, Texas, concluding on July 31, 2023. As a leading distributor of pharmaceutical and medical supplies, Mckesson will deliver drugs to the Federal Correctional Complex Pollock to support the Bureau of Prisons in meeting the medical needs of inmates under its care. No subcontractors or set aside...
Mckesson Corporation, doing business as Mckesson, has been awarded a $436,370 purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock to provide pharmaceuticals. The firm fixed price contract runs from November 1, 2023 through November 30, 2023 and will be performed by Mckesson in Irving, Texas. No subcontractors or set aside designations were specified. The Department of Justice Bureau of Prisons oversees the federal prison system and ensures access to...
Mckesson Corporation will provide pharmaceuticals to the Department of Justice Bureau of Prisons under a one-month, firm fixed price purchase order valued at approximately $1,258. As the prime contractor, Mckesson will deliver the requested medications to the Federal Correctional Complex Pollock in Irving, Texas between November 1st and 30th, 2023. No subcontractors or set aside designations were specified. The Department of Justice Bureau of Prisons manages federal prisons and oversees the...

Mckesson Corporation will provide pharmaceutical products to the Federal Bureau of Prisons under a firm fixed-price purchase order valued at approximately one hundred sixty-one thousand dollars. The one-month contract was awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Cumberland to supply open market pharmaceuticals for the month of October 2023. Place of performance will be Mckesson's distribution center in Irving, Texas. No subcontractors or set-aside designations were identified. This order is likely part of the Bureau of Prisons' larger pharmaceutical supply requirements to meet the healthcare needs of its inmate population nationwide.

Generated 12/14/23, 9:26 PM